Related Experiment Video
Updated: Jun 3, 2026

05:30
Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery
Published on: January 31, 2025
Low-molecular weight plasma proteome analysis using centrifugal ultrafiltration
David W Greening1, Richard J Simpson
1Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Australia.
Methods in Molecular Biology (Clifton, N.J.)
|April 7, 2011
Summary
This study presents a rapid and reproducible method for profiling the low-molecular weight fraction of human plasma. The optimized protocol enables the identification of novel disease biomarkers from plasma samples.
Area of Science:
- Proteomics
- Biomarker Discovery
- Human Plasma Analysis
Background:
- The low-molecular weight fraction (LMF) of human plasma is a rich source of potential disease biomarkers.
- Existing methods for LMF analysis can be time-consuming and lack reproducibility.
- Standardized protocols are needed for efficient LMF profiling.
Purpose of the Study:
- To develop and validate a standardized protocol for rapid and reproducible profiling of the human plasma LMF.
- To enhance the identification of novel plasma-based biomarkers for disease detection.
Main Methods:
- Centrifugal ultrafiltration for plasma fractionation based on molecular size.
- 1D-SDS-PAGE for protein separation.
- Nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) for peptide identification.
Main Results:
- Optimized centrifugal ultrafiltration achieved >95% recovery and enrichment of low-molecular-weight plasma components.
- Identification of over 260 unique peptides from 100 μL of plasma.
- Novel identification of several plasma proteins, including KIAA0649 and transmembrane adapter protein PAG, not previously reported in high-confidence datasets.
Conclusions:
- The developed protocol offers a rapid, reproducible, and efficient method for human plasma LMF profiling.
- This approach significantly expands the repertoire of identified plasma proteins, aiding in biomarker discovery.
- The method facilitates the identification of previously unreported proteins, advancing proteomic research.
